版本:
中国

BRIEF-Capricor Therapeutics q4 loss per share $0.21

March 16 Capricor Therapeutics Inc

* Capricor Therapeutics reports fourth quarter and full year 2016 financial results and provides corporate update

* Q4 loss per share $0.21

* Capricor Therapeutics- sees cash, cash equivalents, marketable securities will fund research and development programs and other operations into q4 2017

* Capricor Therapeutics Inc - expect janssen decision on its license option for cap-1002 by q3 of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐